Singapore-based Sophie’ BioNutrients has recently announced its decision to shift its headquarters to Amsterdam from Singapore.
Sophie’s BioNutrients develops a range of microalgae-based protein flours for plant-based meat and alternative dairy products. Microalgae is a rich source of protein, in addition to containing carbohydrates, polyunsaturated fatty acids, iron and B vitamins.
The decision to relocate is obvious as Sophie’s BioNutrients is targeting manufacturers of plant-based meat and dairy alternatives with a range of protein flours. Eugene Wang, Co-Founder and CEO of Sophie’s Bionutrients sees brighter future of alternative proteins, especially microalgae protein, in Europe. Wang said, “We want to make Europe as our main customer base for the sale of our protein flour.”
The company also received much more enquiries from European companies interested in buying microalgae protein ingredients. Eugene commented that Europeans are far ahead in understanding and using microalgae in food products.
In addition, the pandemic is also partly the cause for the shift as the company wants to be closer to the market for its products, thereby avoiding unnecessary worries and delays over shipping and travel restrictions.
Sophie’s Bionutrients solution lies in microalgae, which it ferments in bioreactors before isolating its proteins and transforming it into a powder for food formulation. It achieved its first Proof of Concept (POC) in a 10L bioreactor in 2018. Last year, it successfully upscaled to 10,000L. It expects its first protein flour, which can be used for solubility, viscosity and foaming in milk, cheese and protein drink products to reach the market in 2021-22. Its second protein flour has a similar timeline but has emulsification properties for meat alternatives. Sophie BioNutrients also plans to make at least another 3 protein flour products within the next 3 years.